Should patients with anaplastic oligodendroglial tumors receive adjuvant chemotherapy?

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Reardon DA et al. (2006) Recent advances in the treatment of malignant astrocytoma. J Clin Oncol 24: 1253–1265

    CAS  Article  PubMed  Google Scholar 

  2. 2

    Buckner JC (2003) Factors influencing survival in high-grade gliomas. Semin Oncol 30 (Suppl 19): S10–S14

    Article  Google Scholar 

  3. 3

    Jaeckle KA et al. (2006) Current strategies in treatment of oligodendroglioma: evolution of molecular signatures of response. J Clin Oncol 24: 1246–1252

    CAS  Article  PubMed  Google Scholar 

  4. 4

    Macdonald DR et al. (1990) Successful chemotherapy for newly diagnosed aggressive oligodendroglioma. Ann Neurol 27: 573–574

    CAS  Article  PubMed  Google Scholar 

  5. 5

    Ino Y et al. (2000) Long survival and therapeutic responses in patients with histologically disparate high-grade gliomas demonstrating chromosome 1p loss. J Neurosurg 92: 983–990

    CAS  Article  PubMed  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Martina Habeck, Associate Editor, Nature Clinical Practice.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Mark R Gilbert.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Gilbert, M., Lang, F. Should patients with anaplastic oligodendroglial tumors receive adjuvant chemotherapy?. Nat Rev Neurol 3, 14–15 (2007). https://doi.org/10.1038/ncpneuro0375

Download citation

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing